Unknown

Dataset Information

0

UCHL3 Regulates Topoisomerase-Induced Chromosomal Break Repair by Controlling TDP1 Proteostasis.


ABSTRACT: Genomic damage can feature DNA-protein crosslinks whereby their acute accumulation is utilized to treat cancer and progressive accumulation causes neurodegeneration. This is typified by tyrosyl DNA phosphodiesterase 1 (TDP1), which repairs topoisomerase-mediated chromosomal breaks. Although TDP1 levels vary in multiple clinical settings, the mechanism underpinning this variation is unknown. We reveal that TDP1 is controlled by ubiquitylation and identify UCHL3 as the deubiquitylase that controls TDP1 proteostasis. Depletion of UCHL3 increases TDP1 ubiquitylation and turnover rate and sensitizes cells to TOP1 poisons. Overexpression of UCHL3, but not a catalytically inactive mutant, suppresses TDP1 ubiquitylation and turnover rate. TDP1 overexpression in the topoisomerase therapy-resistant rhabdomyosarcoma is driven by UCHL3 overexpression. In contrast, UCHL3 is downregulated in spinocerebellar ataxia with axonal neuropathy (SCAN1), causing elevated levels of TDP1 ubiquitylation and faster turnover rate. These data establish UCHL3 as a regulator of TDP1 proteostasis and, consequently, a fine-tuner of protein-linked DNA break repair.

SUBMITTER: Liao C 

PROVIDER: S-EPMC6019701 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

UCHL3 Regulates Topoisomerase-Induced Chromosomal Break Repair by Controlling TDP1 Proteostasis.

Liao Chunyan C   Beveridge Ryan R   Hudson Jessica J R JJR   Parker Jacob D JD   Chiang Shih-Chieh SC   Ray Swagat S   Ashour Mohamed E ME   Sudbery Ian I   Dickman Mark J MJ   El-Khamisy Sherif F SF  

Cell reports 20180601 11


Genomic damage can feature DNA-protein crosslinks whereby their acute accumulation is utilized to treat cancer and progressive accumulation causes neurodegeneration. This is typified by tyrosyl DNA phosphodiesterase 1 (TDP1), which repairs topoisomerase-mediated chromosomal breaks. Although TDP1 levels vary in multiple clinical settings, the mechanism underpinning this variation is unknown. We reveal that TDP1 is controlled by ubiquitylation and identify UCHL3 as the deubiquitylase that controls  ...[more]

Similar Datasets

| S-EPMC3316882 | biostudies-literature
| S-EPMC8151962 | biostudies-literature
| S-EPMC3985661 | biostudies-literature
| S-EPMC8882575 | biostudies-literature
| S-EPMC5578434 | biostudies-literature
| S-EPMC3458563 | biostudies-literature
| S-EPMC6009676 | biostudies-literature
| S-EPMC7846158 | biostudies-literature
| S-EPMC3147608 | biostudies-literature
| S-EPMC3493447 | biostudies-literature